About the journal
Journal of Infection and Public Health is an open-access journal published by Elsevier in United Kingdom, publishing in english. It is listed in DOAJ and MEDLINE according to the sources read. Declared publication charge: 2,310 USD. Declared review time at DOAJ: 21 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Elsevier
- ISSN
- 1876-0341 · 1876-035X
- Country
- United Kingdom
- Languages
- english
- Access
- Open access
- Declared publication charge
- 2,310 USD
- Articles in DOAJ
- 3150
- Declared review time
- 21 weeks
- Declared peer-review model
- double_blind
Index listings
- DOAJ · 2018-06-12
- MEDLINE · 2008-01-01
- Indexing
- DOAJ · MEDLINE
- APC
- 2,310 USD
- Declared review time (DOAJ)
- 21 weeks
- Actual review time (measured)
- 140 days received→accepted — computed from PubMed (n=100)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
3150
Most recent article
2 months ago
Average review time (journal-declared via DOAJ)
21weeks
Works in OpenAlex
3488
Last recorded publication year
2026
h-index
100
i10-index
1583
From OpenAlex open data (CC0).
Editorial & policy12
- Last DOAJ review date
- 2026-04-27
- Added to DOAJ
- 2018-06-12
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSPortico
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 89%
- ORCID iDs in current deposits
- 72%
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity3
- Source type
- journal
- NLM unique ID (PubMed)
- 101487384
- Society affiliations
- Saudi Association for Public Health
Classification4
Subjects (DOAJ)
LCC codes
Subject areas
- Antibiotic Resistance in Bacteria
- Antibiotic Resistance in Bacteria
- COVID-19 Clinical Research Studies
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- SARS-CoV-2 and COVID-19 Research
- Antibiotic Use and Resistance
- Antibiotic Use and Resistance
Show all subjects (50)
- COVID-19 epidemiological studies
- COVID-19 epidemiological studies
- Tuberculosis Research and Epidemiology
- Mosquito-borne diseases and control
- Tuberculosis Research and Epidemiology
- Mosquito-borne diseases and control
- Respiratory viral infections research
- Respiratory viral infections research
- Pneumonia and Respiratory Infections
- Pneumonia and Respiratory Infections
- Nosocomial Infections in ICU
- Nosocomial Infections in ICU
- Long-Term Effects of COVID-19
- Long-Term Effects of COVID-19
- Viral Infections and Outbreaks Research
- Viral Infections and Outbreaks Research
- Antimicrobial Resistance in Staphylococcus
- Antimicrobial Resistance in Staphylococcus
- Influenza Virus Research Studies
- Influenza Virus Research Studies
- Viral Infections and Vectors
- Bacterial Identification and Susceptibility Testing
- Viral Infections and Vectors
- Bacterial Identification and Susceptibility Testing
- Vaccine Coverage and Hesitancy
- Vaccine Coverage and Hesitancy
- Infection Control in Healthcare
- Infection Control in Healthcare
- Malaria Research and Control
- Malaria Research and Control
- COVID-19 and Mental Health
- COVID-19 and Mental Health
- Antifungal resistance and susceptibility
- Antifungal resistance and susceptibility
- Antibiotics Pharmacokinetics and Efficacy
- Antibiotics Pharmacokinetics and Efficacy
- SARS-CoV-2 detection and testing
- SARS-CoV-2 detection and testing
- Viral gastroenteritis research and epidemiology
- Viral gastroenteritis research and epidemiology
- Infection Control and Ventilation
- Hepatitis B Virus Studies
Keywords (DOAJ)
- infection prevention
- public health
- communicable disease
- epidemiology
- infectious disease
- healthcare outcomes
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ